DCGI suspends permission to Entod pharma’s eye drop, company to challenge order in court
New Delhi: Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for ...
Read moreNew Delhi: Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for ...
Read moreNew Delhi: A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the ...
Read moreNew Delhi: The Drug Controller General of India (DCGI) has approved market authorisation to COVID-19 vaccine Covovax as a heterologous ...
Read moreNew Delhi: An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's ...
Read moreNew Delhi: Several anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions ...
Read moreNew Delhi: The Drugs Controller General of India (DCGI) approved Tuesday Bharat Biotech’s intranasal Covid-19 vaccine for restricted emergency use ...
Read moreNew Delhi: Serum Institute of India has informed the Centre that it can supply 1 crore doses of its indigenously ...
Read moreNew Delhi: India’s drug regulator, the Drugs Controller General of India (DCGI) has granted restricted emergency use authorisation (EUA) for ...
Read moreNew Delhi: The Drugs Controller General of India (DCGI) granted permission on Wednesday for conducting the phase-3 clinical trial of ...
Read moreNew Delhi: Serum Institute of India (SII) has sought emergency use authorisation (EUA) from DGCI for its Covid-19 vaccine ‘Covovax’ ...
Read more